These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 23276646)
1. Recommendations on the use of everolimus in lung transplantation. de Pablo A; Santos F; Solé A; Borro JM; Cifrian JM; Laporta R; Monforte V; Román A; de la Torre M; Ussetti P; Zurbano F Transplant Rev (Orlando); 2013 Jan; 27(1):9-16. PubMed ID: 23276646 [TBL] [Abstract][Full Text] [Related]
2. Combination of everolimus with calcineurin inhibitor medication resulted in post-transplant haemolytic uraemic syndrome in lung transplant recipients--a case series. Lovric S; Kielstein JT; Kayser D; Bröcker V; Becker JU; Hiss M; Schiffer M; Sommerwerck U; Haller H; Strüber M; Welte T; Gottlieb J Nephrol Dial Transplant; 2011 Sep; 26(9):3032-8. PubMed ID: 21310739 [TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive therapy in lung transplantation: state of the art. Korom S; Boehler A; Weder W Eur J Cardiothorac Surg; 2009 Jun; 35(6):1045-55. PubMed ID: 19349186 [TBL] [Abstract][Full Text] [Related]
4. From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation. Valantine H; Zuckermann A J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S185-90; discussion S210-1. PubMed ID: 15774320 [TBL] [Abstract][Full Text] [Related]
5. Everolimus: an immunosuppressive agent in transplantation. Patel JK; Kobashigawa JA Expert Opin Pharmacother; 2006 Jul; 7(10):1347-55. PubMed ID: 16805720 [TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Mammalian Target of Rapamycin Inhibitor Use in Heart and Lung Transplantation. Fine NM; Kushwaha SS Transplantation; 2016 Dec; 100(12):2558-2568. PubMed ID: 27495747 [TBL] [Abstract][Full Text] [Related]
11. Suppression of bronchiolitis obliterans in allogeneic rat lung transplantation--effectiveness of everolimus. von Suesskind-Schwendi M; Brunner E; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K Exp Toxicol Pathol; 2013 May; 65(4):383-9. PubMed ID: 22284335 [TBL] [Abstract][Full Text] [Related]
12. Clinical experience with Certican (everolimus) in maintenance heart transplant patients at the Medical University of Vienna. Zuckermann A J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S206-9; discussion S210-1. PubMed ID: 15774324 [TBL] [Abstract][Full Text] [Related]
14. Immunosuppression for lung transplantation. Bhorade SM; Stern E Proc Am Thorac Soc; 2009 Jan; 6(1):47-53. PubMed ID: 19131530 [TBL] [Abstract][Full Text] [Related]
15. Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms. Gomez-Camarero J; Salcedo M; Rincon D; Lo Iacono O; Ripoll C; Hernando A; Sanz C; Clemente G; Bañares R Transplantation; 2007 Sep; 84(6):786-91. PubMed ID: 17893613 [TBL] [Abstract][Full Text] [Related]
17. Recommendations for use of Certican (everolimus) after heart transplantation: results from a German and Austrian Consensus Conference. Hummel M J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S196-200; discussion S210-1. PubMed ID: 15774322 [TBL] [Abstract][Full Text] [Related]
18. Late acute cardiac allograft rejection: new therapeutic options? Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161 [TBL] [Abstract][Full Text] [Related]